413 related articles for article (PubMed ID: 17848651)
1. Carvedilol for children and adolescents with heart failure: a randomized controlled trial.
Shaddy RE; Boucek MM; Hsu DT; Boucek RJ; Canter CE; Mahony L; Ross RD; Pahl E; Blume ED; Dodd DA; Rosenthal DN; Burr J; LaSalle B; Holubkov R; Lukas MA; Tani LY;
JAMA; 2007 Sep; 298(10):1171-9. PubMed ID: 17848651
[TBL] [Abstract][Full Text] [Related]
2. The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design.
Shaddy RE; Curtin EL; Sower B; Tani LY; Burr J; LaSalle B; Boucek MM; Mahony L; Hsu DT; Pahl E; Burch GH; Schlencker-Herceg R
Am Heart J; 2002 Sep; 144(3):383-9. PubMed ID: 12228773
[TBL] [Abstract][Full Text] [Related]
3. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
4. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
[TBL] [Abstract][Full Text] [Related]
5. Adherence with once daily versus twice daily carvedilol in patients with heart failure: the Compliance And Quality of Life Study Comparing Once-Daily Controlled-Release Carvedilol CR and Twice-Daily Immediate-Release Carvedilol IR in Patients with Heart Failure (CASPER) Trial.
Udelson JE; Pressler SJ; Sackner-Bernstein J; Massaro J; Ordronneau P; Lukas MA; Hauptman PJ
J Card Fail; 2009 Jun; 15(5):385-93. PubMed ID: 19477398
[TBL] [Abstract][Full Text] [Related]
6. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.
Bellenger NG; Rajappan K; Rahman SL; Lahiri A; Raval U; Webster J; Murray GD; Coats AJ; Cleland JG; Pennell DJ;
Heart; 2004 Jul; 90(7):760-4. PubMed ID: 15201244
[TBL] [Abstract][Full Text] [Related]
7. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
[TBL] [Abstract][Full Text] [Related]
8. Beta-Blockers (Carvedilol) in Children with Systemic Ventricle Systolic Dysfunction - Systematic Review and Meta-Analysis.
Prijic S; Buchhorn R; Kosutic J; Vukomanovic V; Prijic A; Bjelakovic B; Zdravkovic M
Rev Recent Clin Trials; 2014; 9(2):68-75. PubMed ID: 25198735
[TBL] [Abstract][Full Text] [Related]
9. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
10. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.
Takeda Y; Fukutomi T; Suzuki S; Yamamoto K; Ogata M; Kondo H; Sugiura M; Shigeyama J; Itoh M
Am J Cardiol; 2004 Aug; 94(4):448-53. PubMed ID: 15325927
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary study on the effect of carvedilol on children with primary endocardial fibroelastosis].
Li R; Yi QJ; Qian YR; Liu XY; Zhong JR; Bai YH; Mi Q; Li XL
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):684-7. PubMed ID: 19099859
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.
Packer M; Colucci WS; Sackner-Bernstein JD; Liang CS; Goldscher DA; Freeman I; Kukin ML; Kinhal V; Udelson JE; Klapholz M; Gottlieb SS; Pearle D; Cody RJ; Gregory JJ; Kantrowitz NE; LeJemtel TH; Young ST; Lukas MA; Shusterman NH
Circulation; 1996 Dec; 94(11):2793-9. PubMed ID: 8941104
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
[TBL] [Abstract][Full Text] [Related]
16. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment.
Azeka E; Franchini Ramires JA; Valler C; Alcides Bocchi E
J Am Coll Cardiol; 2002 Dec; 40(11):2034-8. PubMed ID: 12475466
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.
Colucci WS; Packer M; Bristow MR; Gilbert EM; Cohn JN; Fowler MB; Krueger SK; Hershberger R; Uretsky BF; Bowers JA; Sackner-Bernstein JD; Young ST; Holcslaw TL; Lukas MA
Circulation; 1996 Dec; 94(11):2800-6. PubMed ID: 8941105
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic evaluation of children with systemic ventricular dysfunction treated with carvedilol.
Petko C; Minich LL; Everitt MD; Holubkov R; Shaddy RE; Tani LY
Pediatr Cardiol; 2010 Aug; 31(6):780-4. PubMed ID: 20390261
[TBL] [Abstract][Full Text] [Related]
19. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial.
Auerbach SR; Richmond ME; Lamour JM; Blume ED; Addonizio LJ; Shaddy RE; Mahony L; Pahl E; Hsu DT
Circ Heart Fail; 2010 Sep; 3(5):606-11. PubMed ID: 20573993
[TBL] [Abstract][Full Text] [Related]
20. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
